Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
Overview
Citations
- Fidia Farmaceutici S.p.A. (3)
-
| Number |
Title |
Issue Date |
| 4851521 |
Esters of hyaluronic acid |
1989/07/25 |
| 5202431 |
Partial esters of hyaluronic acid |
1993/04/13 |
| 5336767 |
Total or partial esters of hyaluronic acid |
1994/08/09 |
- Angiotech International (2)
-
| Number |
Title |
Issue Date |
| 5290918 |
Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation |
1994/03/01 |
| 5395923 |
Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
1995/03/07 |
- Immuno (1)
-
| Number |
Title |
Issue Date |
| 4909251 |
Tissue adhesive |
1990/03/20 |
- Regents of the University of California, The (1)
-
| Number |
Title |
Issue Date |
| 5773033 |
Fibrinogen/chitosan hemostatic agents |
1998/06/30 |
- FIDIA S.p.A. (1)
-
| Number |
Title |
Issue Date |
| 4957744 |
Cross-linked esters of hyaluronic acid |
1990/09/18 |
- Aventis Behring (1)
-
| Number |
Title |
Issue Date |
| 4650678 |
Readily dissolvable lyophilized fibrinogen formulation |
1987/03/17 |
- JONAS WADSTROM (1)
-
| Number |
Title |
Issue Date |
| 5631011 |
Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
1997/05/20 |
Abstract
Abstract
A fibrin adhesive or sealant composition comprising a biocompatible, bioabsorbable hyaluronic acid material, chitin material, or chitosan material to which fibrinogen and a fibrinogen-cleaving agent are applied, along with other components such as additional coagulation factors, anti-fibrinolytics, stabilizers and biologically active substances. The fibrinogen, fibrinogen-cleaving agent and other components can take the form of dry preparation, an aqueous or nonaqueous preparation, or a combination thereof. Such a composition can be placed directly on, around, or within a wound site and is fully reabsorbed into the body.
Assignees with Similar Patents
Referenced by
- curaseal (7)
-
| Number |
Title |
Issue Date |
| 9993235 |
Enteric fistula treatment devices |
2018/06/12 |
| 9131941 |
Fistula treatment devices and methods |
2015/09/15 |
| 9211116 |
Fistula treatment devices and related methods |
2015/12/15 |
| 8177809 |
Inflatable device for enteric fistula treatment |
2012/05/15 |
| 8206416 |
Inflatable device for enteric fistula treatment |
2012/06/26 |
| 8221451 |
Inflatable device for enteric fistula treatment |
2012/07/17 |
| 8377094 |
Enteric fistula treatment devices |
2013/02/19 |
- xcede technology (7)
-
| Number |
Title |
Issue Date |
| 8999376 |
Tissue patch |
2015/04/07 |
| 9352067 |
Tissue patch |
2016/05/31 |
| 9540548 |
Adhesive compositions and related methods |
2017/01/10 |
| 9833538 |
Adhesive compositions and related methods |
2017/12/05 |
| 9956311 |
Tissue patch |
2018/05/01 |
| 10588998 |
Adhesive compositions and related methods |
2020/03/17 |
| 10722611 |
Adhesive compositions and related methods |
2020/07/28 |
- Endomedix (7)
-
| Number |
Title |
Issue Date |
| 12091471 |
Methods and compositions for achieving hemostasis and stable blood clot formation |
2024/09/17 |
| 9259434 |
Biopolymer system for tissue sealing |
2016/02/16 |
| 8513217 |
Biopolymer system for tissue sealing |
2013/08/20 |
| 9731044 |
Biopolymer system for tissue sealing |
2017/08/15 |
| 10517988 |
Methods and compositions for achieving hemostasis and stable blood clot formation |
2019/12/31 |
| 11033654 |
Methods and compositions for achieving hemostasis and stable blood clot formation |
2021/06/15 |
| 7854923 |
Biopolymer system for tissue sealing |
2010/12/21 |
- PAUZA, KEVIN (5)
-
| Number |
Title |
Issue Date |
| 7597687 |
Injection of fibrin sealant including an anesthetic in spinal applications |
2009/10/06 |
| 8394072 |
Injection of fibrin sealant including an anesthetic in spinal applications |
2013/03/12 |
| 8403895 |
Injection of fibrin sealant including an anesthetic in spinal applications |
2013/03/26 |
| 8419722 |
Apparatus and method for injection of fibrin sealant in spinal applications |
2013/04/16 |
| 8986304 |
Injection of fibrin sealant using reconstituted components in spinal applications |
2015/03/24 |
- Minnesota Mining and Manufacturing (3)
-
| Number |
Title |
Issue Date |
| 10940233 |
Fibrinogen composition, method and wound articles |
2021/03/09 |
| 10137222 |
Fibrin composition, method and wound articles |
2018/11/27 |
| 11827754 |
Fibrin composition comprising carrier material, method and wound articles |
2023/11/28 |
- HEPACORE (2)
-
| Number |
Title |
Issue Date |
| 8329870 |
Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
2012/12/11 |
| 9610357 |
Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof |
2017/04/04 |
- KCI Licensing (1)
-
| Number |
Title |
Issue Date |
| 8469936 |
Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers |
2013/06/25 |
- taiwan hopax chemicals manufacturing (1)
-
| Number |
Title |
Issue Date |
| 8263763 |
Chemically modified polyaminosaccharide by a hydrocarbyl sultone compound |
2012/09/11 |
- RIKEN (1)
-
| Number |
Title |
Issue Date |
| 7722934 |
Biological repair material compatible with biological tissue adhesive |
2010/05/25 |
- Angiotech International (1)
-
| Number |
Title |
Issue Date |
| 6699484 |
Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
2004/03/02 |
- Orthovita (1)
-
| Number |
Title |
Issue Date |
| 9040093 |
Bone graft materials containing calcium phosphate and chitosan |
2015/05/26 |
Tech Analysis
| Class |
Subclass |
Type |
Reference Factor |
Citation Factor |
Strength |
Grant time |
Early grant (%) |
|
424
|
422
|
Emerging |
Average |
Average |
Medium |
Average |
40.2 |
|
424
|
424
|
Stable |
Average |
Average |
Medium |
Average |
44.1 |
|
424
|
425
|
Stable |
Average |
Average |
Medium |
Average |
39.4 |
|
424
|
426
|
Emerging |
Average |
Average |
Medium |
Average |
39.7 |
|
424
|
443
|
Emerging |
Average |
Seminal |
Medium |
Average |
42.0 |
|
424
|
444
|
Stable |
Average |
Average |
Medium |
Average |
48.4 |
|
514
|
13.5
|
Stable |
Sustaining |
Average |
Medium |
Average |
37.1 |
|
514
|
13.6
|
Stable |
Average |
Average |
Medium |
Average |
37.5 |
|
514
|
54
|
Emerging |
Sustaining |
Average |
Medium |
Average |
38.4 |
|
514
|
55
|
Stable |
Average |
Seminal |
Medium |
Average |
39.6 |
|
514
|
56
|
Stable |
Average |
Average |
Medium |
Average |
41.8 |
|
606
|
214
|
Emerging |
Novel |
Seminal |
High |
Average |
25.9 |
|
606
|
215
|
Emerging |
Novel |
Average |
Medium High |
Average |
35.5 |